Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does LEVOFLOXACIN Cause Intentional product use issue? 83 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 83 reports of Intentional product use issue have been filed in association with LEVOFLOXACIN (Levofloxacin). This represents 0.2% of all adverse event reports for LEVOFLOXACIN.

83
Reports of Intentional product use issue with LEVOFLOXACIN
0.2%
of all LEVOFLOXACIN reports
21
Deaths
38
Hospitalizations

How Dangerous Is Intentional product use issue From LEVOFLOXACIN?

Of the 83 reports, 21 (25.3%) resulted in death, 38 (45.8%) required hospitalization, and 15 (18.1%) were considered life-threatening.

Is Intentional product use issue Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for LEVOFLOXACIN. However, 83 reports have been filed with the FAERS database.

What Other Side Effects Does LEVOFLOXACIN Cause?

Drug hypersensitivity (3,660) Neuropathy peripheral (2,619) Arthralgia (2,594) Pain in extremity (2,317) Pain (2,266) Drug ineffective (2,181) Dyspnoea (2,074) Tendonitis (1,813) Aortic aneurysm (1,767) Nausea (1,694)

What Other Drugs Cause Intentional product use issue?

INFLIXIMAB (11,028) RITUXIMAB (9,602) INFLIXIMAB-DYYB (7,549) TOCILIZUMAB (5,078) METHOTREXATE (4,087) PREDNISONE (3,961) ABATACEPT (3,693) ADALIMUMAB (3,557) NIVOLUMAB (3,297) LEFLUNOMIDE (3,280)

Which LEVOFLOXACIN Alternatives Have Lower Intentional product use issue Risk?

LEVOFLOXACIN vs LEVOKETOCONAZOLE LEVOFLOXACIN vs LEVOLEUCOVORIN LEVOFLOXACIN vs LEVOMEPROMAZINE LEVOFLOXACIN vs LEVOMETHADONE LEVOFLOXACIN vs LEVOMILNACIPRAN

Related Pages

LEVOFLOXACIN Full Profile All Intentional product use issue Reports All Drugs Causing Intentional product use issue LEVOFLOXACIN Demographics